Townsquare Capital LLC grew its stake in shares of AMETEK, Inc. (NYSE:AME – Free Report) by 9.3% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 35,678 shares of the technology company’s stock after acquiring an additional 3,041 shares during the quarter. Townsquare Capital LLC’s holdings in AMETEK were worth $6,126,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. B. Riley Wealth Advisors Inc. grew its stake in AMETEK by 42.6% during the 1st quarter. B. Riley Wealth Advisors Inc. now owns 1,919 shares of the technology company’s stock valued at $351,000 after purchasing an additional 573 shares during the last quarter. Tidal Investments LLC increased its stake in shares of AMETEK by 15.1% in the first quarter. Tidal Investments LLC now owns 4,930 shares of the technology company’s stock worth $902,000 after acquiring an additional 646 shares during the period. Comerica Bank raised its holdings in shares of AMETEK by 0.4% during the first quarter. Comerica Bank now owns 74,825 shares of the technology company’s stock worth $13,685,000 after purchasing an additional 314 shares during the last quarter. Citizens Financial Group Inc. RI acquired a new position in AMETEK during the first quarter valued at $542,000. Finally, Swedbank AB purchased a new stake in AMETEK in the first quarter valued at $3,833,000. 87.43% of the stock is owned by hedge funds and other institutional investors.
Insider Buying and Selling
In other AMETEK news, Director Steven W. Kohlhagen sold 1,460 shares of the firm’s stock in a transaction that occurred on Wednesday, September 25th. The shares were sold at an average price of $171.59, for a total value of $250,521.40. Following the transaction, the director now directly owns 23,349 shares of the company’s stock, valued at $4,006,454.91. This trade represents a 5.88 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider David F. Hermance sold 6,243 shares of the company’s stock in a transaction that occurred on Friday, November 8th. The shares were sold at an average price of $190.99, for a total value of $1,192,350.57. Following the completion of the sale, the insider now owns 36,731 shares of the company’s stock, valued at $7,015,253.69. This trade represents a 14.53 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 30,660 shares of company stock worth $5,958,141. 0.61% of the stock is owned by corporate insiders.
AMETEK Stock Performance
AMETEK (NYSE:AME – Get Free Report) last released its quarterly earnings results on Thursday, October 31st. The technology company reported $1.66 earnings per share for the quarter, topping the consensus estimate of $1.62 by $0.04. AMETEK had a net margin of 19.27% and a return on equity of 16.88%. The firm had revenue of $1.71 billion during the quarter, compared to the consensus estimate of $1.71 billion. During the same quarter in the prior year, the firm earned $1.64 EPS. The company’s revenue for the quarter was up 5.3% on a year-over-year basis. As a group, research analysts forecast that AMETEK, Inc. will post 6.8 earnings per share for the current fiscal year.
AMETEK Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, December 20th. Stockholders of record on Friday, December 6th will be paid a $0.28 dividend. This represents a $1.12 dividend on an annualized basis and a dividend yield of 0.57%. The ex-dividend date of this dividend is Friday, December 6th. AMETEK’s dividend payout ratio is presently 19.51%.
Analysts Set New Price Targets
AME has been the subject of several analyst reports. Royal Bank of Canada decreased their price objective on AMETEK from $216.00 to $215.00 and set an “outperform” rating for the company in a report on Friday, August 2nd. TD Cowen lowered AMETEK from a “hold” rating to a “sell” rating in a research report on Monday, October 7th. Robert W. Baird lifted their target price on shares of AMETEK from $166.00 to $186.00 and gave the company a “neutral” rating in a report on Monday, November 4th. Redburn Atlantic upgraded shares of AMETEK to a “strong-buy” rating in a research report on Friday, August 2nd. Finally, KeyCorp lifted their price objective on shares of AMETEK from $205.00 to $215.00 and gave the company an “overweight” rating in a report on Friday, November 22nd. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $199.29.
Check Out Our Latest Analysis on AMETEK
AMETEK Profile
AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices in the North America, Europe, Asia, and South America, and internationally. The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and c devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and sensors for gas turbines and dashboard instruments; heavy trucks, instrumentation, and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry.
Featured Stories
- Five stocks we like better than AMETEK
- How to Invest in Biotech Stocks
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- How to Invest in the Best Canadian StocksĀ
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- How is Compound Interest Calculated?
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Want to see what other hedge funds are holding AME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AMETEK, Inc. (NYSE:AME – Free Report).
Receive News & Ratings for AMETEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMETEK and related companies with MarketBeat.com's FREE daily email newsletter.